Quadrant Capital Group’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.26K	Sell	1,220 -312	-20%	-$1.12K	﹤0.01%	2389
2025 Q4	$5.24K	Buy	1,532 +103	+7%	+$460	﹤0.01%	2360
2025 Q3	$7.19K	Buy	+1,429	New	+$6.3K	﹤0.01%	2248
2025 Q2	–	Sell	-21,946	Closed	-$48.9K	–	1340
2025 Q1	$48.9K	Sell	21,946 -32,763	-60%	-$94K	﹤0.01%	1723
2024 Q4	$160K	Buy	54,709 +24,871	+83%	+$69.3K	0.01%	801
2024 Q3	$77.6K	Buy	29,838 +28,786	+2,736%	+$79.8K	0.01%	1222
2024 Q2	$3.11K	Buy	1,052 +604	+135%	+$2.29K	﹤0.01%	2405
2024 Q1	$2.03K	Sell	448 -1,555	-78%	-$7.93K	﹤0.01%	2505
2023 Q4	$11.4K	Buy	2,003 +1,121	+127%	+$5.2K	﹤0.01%	2015
2023 Q3	$4.06K	Hold	882	–	–	﹤0.01%	2226
2023 Q2	$5.7K	Buy	+882	New	+$6.02K	﹤0.01%	2175